WHO ICTRP trial
A Within-Subject Single Dose Trial on the Effects of Bremelanotide on Social…
ACTRN12615001059550 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12615001059550 |
|---|---|
| Public title | A Within-Subject Single Dose Trial on the Effects of Bremelanotide on Social Cognition and Behaviour |
| Scientific title | Do Males Age 16 Years and Older with Autism Spectrum Disorders show an effect of Bremelanotide on Social Cognition and Behaviour? |
| Primary sponsor | University of Sydney |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | Autism Spectrum Disorder; Autism Spectrum Disorder;Mental Health - Autistic spectrum disorders |
| Interventions | Participants receive both treatments in a random order. Participants are randomised to receive either a single dose subcutaneous injection of 1.75mg of PT-141 or Placebo, followed by a two week wash-out period and then a single dose… |
| Registration date | Dec 10, 2015 |
| Target size | 60 |
| Secondary IDs | Nil unknown |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: